SAFETY AND EFFICACY OF DUAL THERAPY WITH DABRAFENIB AND TRAMETINIB IN AN INFANT WITH BRAF V600E MUTANT INOPERABLE LOW GRADE GLIOMA

被引：0
|
作者：
Green, Sage [1 ]
Walter, Andrew [1 ]
Piatt, Joseph [1 ]
Kaur, Gurcharanjeet [1 ]
机构：
[1] Nemours AI duPont Hosp Children, Wilmington, DE USA
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
10.1093/neuonc/noab090.136
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LGG-12
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [31] Combination of Dabrafenib and Trametinib for the Treatment of Relapsed and Refractory Multiple Myeloma Harboring BRAF V600E Mutation
    Cepulyte, Ruta
    Zucenka, Andrius
    Peceliunas, Valdas
    CASE REPORTS IN HEMATOLOGY, 2020, 2020
  • [32] Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600-Mutant Pediatric High-Grade Glioma
    Hargrave, Darren R.
    Terashima, Keita
    Hara, Junichi
    Kordes, Uwe R.
    Upadhyaya, Santhosh A.
    Sahm, Felix
    Bouffet, Eric
    Packer, Roger J.
    Witt, Olaf
    Sandalic, Larissa
    Kieloch, Agnieszka
    Russo, Mark
    Cohen, Kenneth J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (33) : 5174 - +
  • [33] Successful Treatment with Dabrafenib/Trametinib of a Malignantly Transformed and Metastasized BRAF V600E Mutant Pleiomorphic Xanthoastrocytoma: A Case Report and Review of the Literature
    Vermeulen, Elle
    Vander Mijnsbrugge, An-Sofie
    Brock, Stefanie
    Vaeyens, Freya
    Dirven, Iris
    Cicek, Abdulhamid
    Marcelis, William
    Klein, Samuel
    Bruneau, Michael
    Neyns, Bart
    Duerinck, Johnny
    CASE REPORTS IN ONCOLOGY, 2024, 17 (01): : 10 - 16
  • [34] Efficacy and tolerability of osimertinib with dabrafenib and trametinib in BRAF V600E acquired EGFR-mutant non-small cell lung cancer: a case series
    Lu, Kevin
    Tse, Victoria
    Altaie, Ghaith
    Husain, Hatim
    JOURNAL OF THORACIC DISEASE, 2024, 16 (08) : 5379 - 5387
  • [35] Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation
    Dotsu, Yosuke
    Fukuda, Minoru
    Honda, Noritaka
    Gyotoku, Hiroshi
    Kohno, Yoshihisa
    Suyama, Takayuki
    Umeyama, Yasuhiro
    Taniguchi, Hirokazu
    Takemoto, Shinnosuke
    Yamaguchi, Hiroyuki
    Miyazaki, Taiga
    Sakamoto, Noriho
    Obase, Yasushi
    Ikeda, Hiroaki
    Ashizawa, Kazuto
    Mukae, Hiroshi
    THORACIC CANCER, 2021, 12 (02) : 272 - 276
  • [36] The effects of dabrafenib and/or trametinib treatment in Braf V600-mutant glioma: a systematic review and meta-analysis
    Lei, Jun
    Liu, Yanhui
    Fan, Yingjun
    NEUROSURGICAL REVIEW, 2024, 47 (01)
  • [37] Safety and Efficacy of Dabrafenib Plus Trametinib in Chinese Patients With BRAF V600E-Mutation Positive Metastatic NSCLC
    Fan, Y.
    Jianying, Z.
    Yuanyuan, Z.
    Yan, Y.
    Nong, Y.
    Juan, L.
    Jialei, W.
    Jun, Z.
    Zhehai, W.
    Jun, C.
    Zhu, T.
    Li, H.
    Li, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S423 - S423
  • [38] Combined BRAF and MEK Inhibition with Dabrafenib and Trametinib in BRAF V600-mutant colorectal cancer
    Loir, E.
    Cochereau, D.
    ONCOLOGIE, 2016, 18 (9-10) : 565 - 566
  • [39] Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer
    Corcoran, Ryan B.
    Atreya, Chloe E.
    Falchook, Gerald S.
    Kwak, Eunice L.
    Ryan, David P.
    Bendell, Johanna C.
    Hamid, Omid
    Messersmith, Wells A.
    Daud, Adil
    Kurzrock, Razelle
    Pierobon, Mariaelena
    Sun, Peng
    Cunningham, Elizabeth
    Little, Shonda
    Orford, Keith
    Motwani, Monica
    Bai, Yuchen
    Patel, Kiran
    Venook, Alan P.
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (34) : 4023 - +
  • [40] Comment on: Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib
    Bourque, Melissa S.
    Salek, Marta
    Sabin, Noah D.
    Canale, Meredith
    Upadhyaya, Santhosh A.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (04)
12345